ARCHIVES

AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Regional Groups: Why 15 Were Not Among Those Funded; Cancer Regional Studies Review Committee Chartered

July 2, 1982

Also Stillman named director, Cold Spring Harbor, Watson is chancellor.

December 12, 2003

NCAB, President’s Cancer Panel honor the late Paul Calabresi.

June 11, 2004

DCT Board Okays Concepts Of Four New Grant Projects, Four Competitive Contract Delays Chlordane Study

March 9, 1984

DRCCA To Get Name Change, Three Major Program Areas

August 27, 1982

ONS Award Winners, Grantees, Announced At Annual Congress

July 27, 1990